Volume 9 Issue 3
Jun.  2019
Turn off MathJax
Article Contents
A.R. Pinho, A. Fortuna, A. Falc(a)o, A.C. Santos, R. Sei(c)a, C. Estevens, F. Veiga, A.J. Ribeiro. Comparison of ELISA and HPLC-MS methods for the determination of exenatide in biological and biotechnology-based formulation matrices[J]. Journal of Pharmaceutical Analysis, 2019, 9(3): 143-155.
Citation: A.R. Pinho, A. Fortuna, A. Falc(a)o, A.C. Santos, R. Sei(c)a, C. Estevens, F. Veiga, A.J. Ribeiro. Comparison of ELISA and HPLC-MS methods for the determination of exenatide in biological and biotechnology-based formulation matrices[J]. Journal of Pharmaceutical Analysis, 2019, 9(3): 143-155.

Comparison of ELISA and HPLC-MS methods for the determination of exenatide in biological and biotechnology-based formulation matrices

  • Publish Date: Jun. 10, 2019
  • The development of biotechnology-based active pharmaceutical ingredients, such as GLP-1 analogs, brought changes in type 2 diabetes treatment options. For better therapeutic efficiency, these active pharmaceutical ingredients require appropriate administration, without the development of adverse effects or toxicity. Therefore, it is required to develop several quantification methods for GLP-1 analogs products, in order to achieve the therapeutic goals, among which ELISA and HPLC arise. These methods are developed, optimized and validated in order to determine GLP-1 analogs, not only in final formu-lation of the active pharmaceutical ingredient, but also during preclinical and clinical trials assessment. This review highlights the role of ELISA and HPLC methods that have been used during the assessment for GLP-1 analogs, especially for exenatide.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (133) PDF downloads(8) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return